Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Boehringer Ingelheim GmbH -Company Report'
Title Publication Date Price Relevance
Boehringer Ingelheim GmbH
Strategic Analysis Profile
 Feb 2008 £500 100%
Boehringer Ingelheim GmbH-Therapeutic Competitors Report Mar 2011 £220 99%
Boehringer Ingelheim GmbH Strategic Analysis Profile Dec 2007 £500 99%
Boehringer Ingelheim GmbH-Deals & Alliances Report Mar 2011 £380 99%
Boehringer Ingelheim RCV GmbH & Co KG-Therapeutic Competitors Report Mar 2011 £220 99%
Boehringer Ingelheim GmbH
Market Share Analysis
 Sep 2010 £630 99%
Boehringer Ingelheim GmbH Market Share Analysis Sep 2010 £630 98%
Boehringer Ingelheim GmbH – Product Pipeline Review
H2 2011
 Nov 2011 £315 98%
Boehringer Ingelhgeim GmbH: PharmaVitae Model Jan 2009 £3,605 90%
OTC Pharmaceuticals in Austria
Industry and Country Analysis
 Aug 2011 £250 89%
OTC Pharmaceuticals in Mexico Nov 2010 £160 89%
Digestive Remedies in Germany Apr 2011 £600 89%
OTC Obesity - Germany Apr 2010 £600 88%
Wound Treatments - Germany Apr 2010 £600 88%
Slimming Products - Germany Apr 2010 £600 88%
Analgesics in Germany Apr 2011 £600 87%
Herbal/Traditional Products in Germany Apr 2011 £600 87%
Vitamins and Dietary Supplements in Germany Apr 2011 £600 86%
Medicated Skin Care in Germany Apr 2011 £600 86%
Calming and Sleeping in Germany Apr 2011 £600 86%
Cough, Cold and Allergy (Hay Fever) Remedies in Germany Apr 2011 £600 84%
OTC Pharmaceuticals - North America (NAFTA) Industry Guide Nov 2010 £505 82%
Keys for Pharma Success: Integrating Social May 2011 £395 81%
Tourette Syndrome Global Clinical Trials Review
Q1, 2011
 Jan 2011 £630 81%
Veterinary Vaccines Feb 2011 £2,845 80%
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide Nov 2010 £630 79%
DPP IV Inhibitors Sep 2011 £2,655 79%
Anxiety Disorders Apr 2011 £3,035 78%
The Pharmaceutical Market: Germany Oct 2011 £595 77%
Thromboembolism - Pipeline Review
H2 2011
 Nov 2011 £315 77%